13.04.2021 • News

DSM Launches Personalized Health Tech Company

DSM has invested $100 million in the launch of Hologram Sciences, a health tech company that will provide consumers with personalized nutrition solutions.

The newly formed company aims to create brands that target various health conditions, combining health diagnostics, digital coaching and personalized nutrition solutions that DSM said have been clinically proven to address a variety of needs, such as those related to immunity, the gut and brain.

Along with nutritional supplements and diagnostics, the company’s proprietary digital platform will provide consumers with access to registered dieticians.

Dimitri de Vreeze, co-CEO at DSM commented: “We’re thrilled to fund a powerful, data-driven platform that’s fused with DSM’s capabilities and product resources. With the help of key experts – including nutritionists, dietitians, scientists and advisors – Hologram Sciences will be taking personalized nutrition to a new level for consumers and DSM’s customers.”

Once validated in-market, DSM said the custom-formulated solutions will be available to its customers, adding that Hologram will also work to incubate products with DSM customers and partners, based on the latest consumer insights.

Hologram will be led by Ian Brady, co-founder of US-based financial services firm SoFi. “With a highly dynamic team combining expertise in tech, brand marketing, and the nutrition innovation and science power of DSM, we can reveal that our first solution will be a rapid immunity concept, addressing the current acute concern over the ongoing Covid-19 pandemic,” Brady said.

Author: Elaine Burridge, Freelance Journalist

DSM has invested $100 million in the launch of Hologram Sciences, a health tech...
DSM has invested $100 million in the launch of Hologram Sciences, a health tech company that will provide consumers with personalized nutrition solutions. Hologram aims to create brands that target various health conditions, including those related to immunity, the gut and brain. (c) Hologram Sciences

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read